The expanding availability of multiple therapeutic strategies and sequencing options for renal cell carcinoma (RCC) has increased the importance of skilled individualized outcome estimation for patients. In this Review, the authors examine a number of the available statistical models for the management of patients with RCC and highlight those most likely to be of use in a busy clinical setting.
- Lui Shiong Lee
- Min-Han Tan
